Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pancreatic cancer

Published:2017-04 Issue:4 Volume:19 Page:473-485
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Aoki Taku,Matsushita Hirokazu,Hoshikawa Mayumi,Hasegawa Kiyoshi,Kokudo Norihiro,Kakimi Kazuhiro

Funder

Grant-in-Aid for Scientific Research

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference33 articles.

1. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial;Oettle;JAMA,2013

2. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial;Oettle;JAMA,2007

3. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01);Uesaka;Lancet,2016

4. Human gammadelta T cells: a nonredundant system in the immune-surveillance against cancer;Ferrarini;Trends Immunol,2002

5. Harnessing gammadelta T cells in anticancer immunotherapy;Hannani;Trends Immunol,2012

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. γδ T cells as critical anti-tumor immune effectors;Nature Cancer;2024-07-26

2. The double life of a chemotherapy drug: Immunomodulatory functions of gemcitabine in cancer;Cancer Medicine;2024-05

3. Isolation and expansion of pure and functional γδ T cells;Frontiers in Immunology;2024-02-15

4. Immune modulators for pancreatic ductal adenocarcinoma therapy;Immune Landscape of Pancreatic Cancer Development and Drug Resistance;2024

5. Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation;Biomedical Journal;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3